頁籤選單縮合
題名 | 主動提供結核病人愛滋病檢測之介入成效暨未進行愛滋病檢驗之原因分析=Enhancing Integration of HIV Testing into TB Control Program and Factors Associated with Refusal of HIV Testing in Taiwan, July 2013~June 2014 |
---|---|
作者 | 謝宛庭; 邱美玉; 李品慧; 詹珮君; 楊祥麟; 許建邦; 黃彥芳; 陳昶勳; Hsieh, Wan-ting; Chiou, Mei-yu; Lee, Pin-hui; Chan, Pei-chun; Yang, Shiang-lin; Hsu, Chien-bang; Huang, Yen-fang; Chen, Chang-hsun; |
期刊 | 疫情報導 |
出版日期 | 20170314 |
卷期 | 33:5 2017.03.14[民106.03.14] |
頁次 | 頁29-30+83-89 |
分類號 | 415.944 |
語文 | chi |
關鍵詞 | 結核病; 愛滋病; 愛滋病毒檢驗; Tuberculosis; TB; People living with human immunodeficiency virus; PLWH; HIV testing; |
中文摘要 | 愛滋病毒感染盛行率與結核病發生率有共伴效應,愛滋病毒感染者之結核病發病風險是非愛滋病毒感染者的29倍,且合併感染對於治療及預後影響甚鉅。世界衛生組織建議應提供愛滋病檢測及諮詢服務給所有疑似或確診之結核病個案。考量我國青壯年族群結核病個案之愛滋病毒感染盛行率較其他年齡族群高,且有逐年增加之趨勢,故疾病管制署自2013年6月27日起推動15–49歲確診或使用抗結核藥物個案接受愛滋病毒檢驗之服務。研究結果顯示2013年7月至2014年6月期間內,檢驗率有逐步上升之趨勢,全國平均愛滋病毒檢驗率為75.4%,主動發現率達0.6%。因此,推動該策略對於在青壯年族群結核病個案中主動發現愛滋病毒感染者相當具有效益,且這群結核病及愛滋病毒感染者接受高效能抗愛滋病毒治療涵蓋率達89.7%。此外,未接受愛滋病毒檢驗之考量因素主要為「自認感染風險低」(42.3%),其次為「認為檢驗與否重要性不大」(36.1%)。針對此結果彙集常見問題並撰寫回覆說帖,提供業務相關人員參考,以利實務執行順遂。建議未來應加強愛滋病毒感染者常規結核病篩檢,以利早期主動發現結核病個案,並進一步規劃將潛伏結核感染檢驗及治療導入愛滋病毒感染者之個案照護過程。 |
英文摘要 | People living with human immunodeficiency virus (PLWH) had 29 times higher risk to develop active tuberculosis (TB) than non-HIV infected persons, and TB was still the leading cause of death among PLWH. Collaborative management of TB/HIV had been recommended by WHO that aimed to reduce the burden of TB and HIV co-infection in affected populations. The TB control program in Taiwan endorsed active HIV counseling and testing, or encouraging HIV testing in TB care facilities by public health staff for TB patients aged 15–49 years old of unknown HIV status since June 27, 2013. A total of 3,533 TB patients were eligible during July 2013 to June 2014 after excluding 63 patients who had been identified HIV co-infection before notification of TB disease. We found that 2,664 TB patients (75.4 %) received HIV testing with the increasing trend of testing proportion during the study period. This intervention identified newly diagnosed HIV infected TB patients and referred them to initiate highly active anti-retroviral therapy (HAART) treatment. Among them, up to 89.7% received HAART. The main reasons that patients refused HIV testing were having low risk to get HIV infection (42.3%); and not important to test HIV (36.1%). In the future, we suggest enhancing TB screening in HIV control program and isoniazid preventive therapy (IPT) for PLWH. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。